An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.
Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.
New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.
The European Commission on Thursday (6 May) responded to a US declaration of support for the TRIPS waiver, stating that they were open to further discussions without explicit agreement.
The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.
A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
The TRIPS waiver would temporarily stop an intellectual property law that stops poorer countries to manufacture the vaccine - the US now joins India and South Africa in the proposal.
A patient with vaccine-inducted thrombotic thrombocytopenia was successfully treated with a heparin alternative, after receiving the Johnson & Johnson vaccine.
A study by Annenberg Public Policy Center (APPC) researchers has found that users of conservative and social media are more likely to believe COVID-19 conspiracy theories.
